ARTICLE | Company News

Lundbeck, Otsuka Pharmaceutical sales and marketing update

March 24, 2014 7:00 AM UTC

H. Lundbeck and Otsuka launched once-monthly, intramuscular Abilify Maintena aripiprazole in Europe for maintenance treatment of schizophrenia in adults stabilized with once-daily oral aripiprazole. Otsuka said the price in Denmark, the first country to fully reimburse the product, is DKK3,558.60 ($661.90) per month. The product is approved in the EU and U.S., where it was launched in March 2013. ...